Abstract

Introduction: Dyslipidaemia is one of the major risk factor for cardiovascular disease in Type 2 Diabetes mellitus, characterized by elevated Total cholesterol (TC), Triglycerides (TG), Low density lipoprotein (LDL) and decreased High density lipoprotein (HDL). Haemoglobin A1c (HbA1c) is widely used as an index of mean glycaemia, a measure of risk for the development of diabetes complications and a measure of the quality of diabetes care. The aim of this study was to determine the impact of glycaemic control on lipid profile and to know utility of HbA1c as an indirect indicator of dyslipidaemia. Objectives: To assess the relationship between glycemic control (HbA1c) and serum lipid profile as well as to evaluate the importance of HbA1c as an indicator of dyslipidemia in patients with T2DM. Materials and Methods: The present study is a prospective, observational study which is conducted in the Department of General Medicine at Surabhi Institute of Medical Sciences over a period of 6 months. A total of 65 T2DM patients with dyslipidemia who had visited the hospital. Inclusion criteria: Adults aged above 30 years and having Type 2 Diabetes Mellitus with dyslipidaemia.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call